LILY34:BVMF
Eli Lilly And Company BDR
R$196.79
0.00%
(0.00) 1D
Okt 9, 5:06:00 PM GMT-3 · BRL
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa LILY34...
Buksan
R$195.67
Mataas
R$196.79
Mababa
R$191.80
Mkt. cap
1.11T
Avg. na dami
36.60K
Dami
41.76K
Mataas nang 52-wk
R$223.07
Mababa nang 52-wk
R$141.56
Mga natitirang share
941.36M
Bilang ng mga empleyado
50K
Buksan
R$195.67
Mataas
R$196.79
Mababa
R$191.80
Mkt. cap
1.11T
Avg. na dami
36.60K
Dami
41.76K
Mataas nang 52-wk
R$223.07
Mababa nang 52-wk
R$141.56
Mga natitirang share
941.36M
Bilang ng mga empleyado
50K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
The Globe and Mail
·
5 oras ang nakalipas
4 Healthcare Stocks Worth Owning for the Next Decade
Investing.com UK
·
6 oras ang nakalipas
RBC Capital reiterates Eli Lilly stock rating on incretin momentum By Investing.com
The Motley Fool
·
6 oras ang nakalipas
This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here's What This Could Mean for the Stock
ad-hoc-news.de
·
10 oras ang nakalipas
Eli Lilly presented new trial data. Eli Lilly stock gains 1.09 percent
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Tungkol sa Eli Lilly And Company BDR
CEODavid A. Ricks
Mga Empleyado50K
Itinatag1876
HeadquartersIndianapolis, Indiyana, Estados Unidos
Sektor-
Websitelilly.com